1. 96-Week Results of Abacavir/Lamivudine versus Tenofovir/Emtricitabine, plus Efavirenz, in Antiretroviral-Naive, HIV-1-Infected Adults: Assert Study. Issue 7 (October 2013) Authors: Moyle, Graeme J; Stellbrink, Hans-Jürgen; Compston, Juliet; Orkin, Chloe; Arribas, José R; Domingo, Pere; Granier, Catherine; Pearce, Helen; Sedani, Sangeeta; Gartland, Martin Journal: Antiviral therapy Issue: Volume 18:Issue 7(2013) Page Start: 905 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Brief Report: Durable Suppression and Low Rate of Virologic Failure 3 Years After Switch to Dolutegravir + Rilpivirine 2-Drug Regimen. (1st November 2020) Authors: van Wyk, Jean; Orkin, Chloe; Rubio, Rafael; Bogner, Johannes; Baker, David; Khuong-Josses, Marie-Aude; Parks, David; Angelis, Konstantinos; Kahl, Lesley P.; Matthews, Jessica; Wang, Ruolan; Underwood, Mark; Wynne, Brian; Nascimento, Maria-Claudia; Vandermeulen, Kati; Gartland, Martin; Smith, Kimb... Journal: Journal of acquired immune deficiency syndromes Issue: Volume 85:Number 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Brief Report: Virologic Response by Baseline Viral Load With Dolutegravir Plus Lamivudine vs Dolutegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine. (1st May 2020) Authors: Eron, Joseph; Hung, Chien-Ching; Baril, Jean-Guy; Slim, Jihad; Falcó, Vicenç; Bogner, Johannes; Maggiolo, Franco; Mills, Anthony; Sievers, Jörg; Man, Choy Y.; Urbaityte, Rimgaile; Underwood, Mark; Tenorio, Allan R.; Pappa, Keith A.; Wynne, Brian; Koteff, Justin; Gartland, Martin; Smith, Kimberly ... Journal: Journal of acquired immune deficiency syndromes Issue: Volume 84:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials. Issue 10167 (12th January 2019) Authors: Cahn, Pedro; Madero, Juan Sierra; Arribas, José Ramón; Antinori, Andrea; Ortiz, Roberto; Clarke, Amanda E; Hung, Chien-Ching; Rockstroh, Jürgen K; Girard, Pierre-Marie; Sievers, Jörg; Man, Choy; Currie, Alexander; Underwood, Mark; Tenorio, Allan R; Pappa, Keith; Wynne, Brian; Fettiplace, Anna; Ga... Journal: Lancet Issue: Volume 393:Issue 10167(2019) Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial. Issue 3 (March 2019) Authors: Aboud, Michael; Kaplan, Richard; Lombaard, Johannes; Zhang, Fujie; Hidalgo, José A; Mamedova, Elmira; Losso, Marcelo H; Chetchotisakd, Ploenchan; Brites, Carlos; Sievers, Jörg; Brown, Dannae; Hopking, Judy; Underwood, Mark; Nascimento, Maria Claudia; Punekar, Yogesh; Gartland, Martin; Smith, Kimb... Journal: Lancet infectious diseases Issue: Volume 19:Issue 3(2019) Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment–Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials. (1st March 2020) Authors: Cahn, Pedro; Madero, Juan Sierra; Arribas, José R.; Antinori, Andrea; Ortiz, Roberto; Clarke, Amanda E.; Hung, Chien-Ching; Rockstroh, Jürgen K.; Girard, Pierre-Marie; Sievers, Jörg; Man, Choy Y.; Urbaityte, Rimgaile; Brandon, Daisy J.; Underwood, Mark; Tenorio, Allan R.; Pappa, Keith A.; Wynne, ... Journal: Journal of acquired immune deficiency syndromes Issue: Volume 83:Number 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and safety of dolutegravir–rilpivirine for maintenance of virological suppression in adults with HIV-1: 100-week data from the randomised, open-label, phase 3 SWORD-1 and SWORD-2 studies. Issue 9 (September 2019) Authors: Aboud, Michael; Orkin, Chloe; Podzamczer, Daniel; Bogner, Johannes R; Baker, David; Khuong-Josses, Marie-Aude; Parks, David; Angelis, Konstantinos; Kahl, Lesley P; Blair, Elizabeth A; Adkison, Kimberly; Underwood, Mark; Matthews, Jessica E; Wynne, Brian; Vandermeulen, Kati; Gartland, Martin; Smit... Journal: Lancet Issue: Volume 6:Issue 9(2019) Page Start: e576 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies. Issue 10123 (3rd March 2018) Authors: Llibre, Josep M; Hung, Chien-Ching; Brinson, Cynthia; Castelli, Francesco; Girard, Pierre-Marie; Kahl, Lesley P; Blair, Elizabeth A; Angelis, Kostas; Wynne, Brian; Vandermeulen, Kati; Underwood, Mark; Smith, Kim; Gartland, Martin; Aboud, Michael Journal: Lancet Issue: Volume 391:Issue 10123(2018) Page Start: 839 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Initial viral load decline and response rates by baseline viral load strata with dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: pooled results from the GEMINI studies. Issue 2 (March 2019) Authors: Eron, Joseph; Hung, Chien-Ching; Baril, Jean-Guy; Slim, Jihad; Falcó, Vicenç; Bogner, Johannes; Maggiolo, Franco; Mills, Anthony; Sievers, Jörg; Man, Choy Y.; Currie, Alexander; Underwood, Mark; Tenorio, Allan; Pappa, Keith A.; Wynne, Brian; Koteff, Justin; Gartland, Martin; Smith, Kimberly Y.; A... Journal: Journal of infection and public health Issue: Volume 12:Issue 2(2019) Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254 . (6th January 2022) Authors: Spinner, Christoph D; Felizarta, Franco; Rizzardini, Giuliano; Philibert, Patrick; Mitha, Essack; Domingo, Pere; Stephan, Christoph J; DeGrosky, Michelle; Bainbridge, Veronica; Zhan, Joyce; Dumitrescu, Teodora Pene; Jeffrey, Jerry L; Xu, Jianfeng; Halliday, Fiona; Gan, Jianjun; Johnson, Mark; Gar... Journal: Clinical infectious diseases Issue: Volume 75:Number 5(2022) Page Start: 786 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗